The NAFTA Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The pharmaceuticals industry within the NAFTA countries had a total market value of $412.0 billion in 2020. The US was the fastest growing country, with a CAGR of 4.7% over the 2016-20 period.
- Within the pharmaceuticals industry, the US is the leading country among the NAFTA bloc, with market revenues of $387.0 billion in 2020. This was followed by Canada and Mexico, with a value of $20.2 and $4.8 billion, respectively.
- The US is expected to lead the pharmaceuticals industry in the NAFTA bloc, with a value of $441.0 billion in 2025, followed by Canada and Mexico with expected values of $19.4 and $4.9 billion, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the NAFTA pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ NAFTA operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA pharmaceuticals market with five year forecasts
- Compares data from the US, Canada and Mexico, alongside individual chapters on each country
Reasons to Buy
- What was the size of the NAFTA pharmaceuticals market by value in 2020?
- What will be the size of the NAFTA pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the NAFTA pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the NAFTA pharmaceuticals market?
Table of Contents
1 Introduction
2 NAFTA Pharmaceuticals
3 Pharmaceuticals in Canada
4 Pharmaceuticals in Mexico
5 Pharmaceuticals in The United States
6 Company Profiles
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Johnson & Johnson
- Pfizer Inc.
- Apotex, Inc.
- Merck & Co., Inc.
- Sanofi SA
- Genomma Lab Internacional SAB de CV
- AstraZeneca PLC